Improving understanding and treatment of Sjögren's syndrome
Sjögren's International Collaborative Clinical Alliance Next Generation Studies (SICCA-NextGen)
This study is working to improve how Sjögren's syndrome is diagnosed and treated by gathering important health information and samples from many people, so that researchers can better understand the condition and help patients feel better.
Quick facts
| Grant type | U01 cooperative agreement |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of California, San Francisco NIH-funded |
| Lab location | 1 site (San Francisco, United States) |
| Project ID | NIH-10885914 on NIH RePORTER |
What this research studies
This research focuses on enhancing the diagnosis and treatment of Sjögren's syndrome (SS) by developing standardized classification criteria and creating a comprehensive data and biospecimen repository. The project involves collaboration among nine leading academic research groups worldwide, collecting detailed clinical data and biological samples from a large cohort of participants. This information will be used for future studies on the epidemiology, pathogenesis, and genetics of SS, ultimately aiming to improve patient outcomes.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with Sjögren's syndrome or those exhibiting symptoms of the condition.
Not a fit: Patients without a diagnosis of Sjögren's syndrome or related autoimmune conditions may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to better diagnosis and treatment options for patients with Sjögren's syndrome.
How similar studies have performed: Previous research efforts in this area have shown success in developing classification criteria and biorepositories for autoimmune diseases, indicating a promising approach.
Where this research is happening
San Francisco, United States
- University of California, San Francisco — San Francisco, United States (Active)
Researchers
- Principal investigator: Shiboski, Caroline Helene — University of California, San Francisco
- Study coordinator: Shiboski, Caroline Helene
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.